TCL Archive NCI Announces New CREG Offer For In Vitro Chemical Carcinogenesis Tests November 21, 1975
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Senate Bill Gives NIH $23.7 Billion, NCI $4.25 Billion, Better Than House. November 2, 2001
TCL Archive SPOREs hammer out research agenda, seek $50,000 from NCI for further tissue analysis. April 30, 2004
